Scientists have discovered that amniotic fluid has amazing healing powers. The groundbreaking results are potentially life-changing for millions of Australians suffering debilitating diseases.
While mums already know just how incredible amniotic fluid is in protecting and nourishing our babies for nine months, it seems this liquid gold could actually have powers beyond the womb.
discovered that cells from pregnant women could prevent fractures by almost 80 per cent.
It has the potential to change the lives of people living with osteoporosis and brittle bone disease. It could even help strengthen the fragile bones of astronauts on long space journeys.
“Amniotic stem cells are quick, easy and safe to obtain,” explained lead researcher Pascale V Guillot from University College London GOS Institute of Child Health.
“This is the first time this type of stem cell has been used to successfully strengthen bones and improve their quality.
“The discovery could have a profound effect on the lives of patients who have fragile bones and could stop a large number of their painful fractures.”
Positive results during lab testing
The researchers injected newborn mice suffering brittle bone disease with amniotic stem cells. They then compared their bones to those of mice with brittle bone disease who weren’t injected with the cells.
What they discovered is that the amniotic fluid cells seemed to protect the fragile bones of the mice, increasing their strength, plasticity, structure and tissue quality.
If the cells have the same effect in humans, it would mean less fractures and less chronic pain. Researchers hope that the treatment would actually end all of the symptoms of these diseases.
Osteoporosis and brittle bone disease in Australia
More than one million Australians have osteoporosis and is most common in people over the age of 50.
Osteogenesis Imperfecta is also known as brittle bone disease. It’s estimated that seven people out of every 100,000 are born with this genetic condition. It primarily affects bones, causing them to be fragile.
The research teams is hoping to start clinical human trials in the next one to two years.
Meanwhile, have you seen this photo of a baby born inside the amniotic sac?